View Older Stories View More Recent Stories

Apr 6, 2017 07:52AM Maxim Group Downgrades Fifth Street Senior (FSFR) to Hold
Apr 5, 2017 11:22AM BioLineRx Closes $28.75 Million Underwritten Public Offering of its American Depositary Shares
Apr 4, 2017 05:28PM TICC Capital Corp. Prices Public Offering of $57.5 Million 6.50% Notes Due 2024
Apr 4, 2017 09:00AM New Age Beverages Corporation Announces Investor Conference Call to Discuss 2016 Results
Apr 4, 2017 03:01AM Versus Systems to Present at the MicroCap Conference in New York City at the Essex House
Apr 3, 2017 04:23PM TICC Capital Corp. Announces Offering of Notes
Apr 3, 2017 04:05PM Seanergy Maritime Holdings Corp. Reports Financial Results for the Fourth Quarter and Twelve Months Ended December 31, 2016
Apr 3, 2017 03:20PM Sucampo Pharmaceuticals (SCMP) PT Raised to $21 at Maxim Group; Vtesse 'Could Be a Great Deal'
Apr 3, 2017 07:39AM Kite Pharma (KITE) PT Raised to $100 at Maxim Group
Mar 31, 2017 06:13PM First Capital Real Estate Trust Incorporated And PhotoMedex, Inc. Announce Entry Into Contribution Agreement
Mar 31, 2017 08:27AM BioLineRx (BLRX) Prices 29.4M Offering at $0.85/ADS
Mar 31, 2017 08:25AM BioLineRx Prices $25 Million Underwritten Public Offering
Mar 31, 2017 08:04AM Cytosorbents (CTSO) Prices 2.22M Share Follow-On Offering at $4.50
Mar 31, 2017 08:00AM CytoSorbents Announces Pricing of Follow-On Offering
Mar 31, 2017 07:46AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast Limited (MESO); 'Locking the Database Up for Interim Analysis'
Mar 31, 2017 07:33AM Maxim Group Upgrades Vertex (VRTX) to Buy
Mar 30, 2017 10:49AM Maxim Group Reiterates Buy Rating and $11 PT on Intec Phara (NTEC); 'Ph3 Accordian Study Unfolding as Planned'
Mar 30, 2017 10:44AM Maxim Group Reiterates Buy Rating and $22 PT on Omeros (OMER) Following Positive OMS721 Phase 2 Trial Data
Mar 30, 2017 10:34AM Maxim Group Reiterates Buy Rating and $11 PT on AEterna Zentaris (AEZS) Following News of Macrilen NDA in 3Q17
Mar 30, 2017 09:33AM Brainstorm Cell Therapeutics (BCLI) PT Raised to $8 at Maxim Group
Mar 29, 2017 10:31AM Maxim Group Downgrades Ritter Pharmaceuticals (RTTR) to Hold
Mar 28, 2017 12:11PM Maxim Group Reiterates Buy Rating and $22 PT on Omeros (OMER) Following OMS721 Positive Case Report
Mar 28, 2017 08:30AM First Choice Healthcare Solutions to Present at the Microcap Conference on April 4, 2017 in New York City
Mar 28, 2017 07:49AM Maxim Group Reiterates Buy and $32 PT on Zynerba Pharma (ZYNE) Following 4Q Results; 'P2 POC Data in Epilepsy Approaching in 3Q17'
Mar 28, 2017 07:29AM Maxim Group Starts VistaGen Therapeutics (VTGN) at Buy
Mar 24, 2017 07:58AM Maxim Group Reiterates Hold Rating on NovaBay Pharma (NBY) Following 4Q Results
Mar 24, 2017 07:42AM Maxim Group Maintain Buy Rating and $9 PT on Galmed Pharma (GLMD) Following Q4 EPS Miss; 'Lack of N-T Catalysts'
Mar 24, 2017 07:35AM Maxim Group Reiterates Buy Rating and $9 PT on Intec Pharma (NTEC) Following Ph1 Trial Initiation of CBD/THC Using the Accordion Delivery System
Mar 23, 2017 09:02AM Interpace Diagnostics (IDXG) Enters Agreement to Restructure Debt and Terminate Royalty and Milestone Obligations
Mar 23, 2017 09:00AM Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations
Mar 23, 2017 08:14AM Maxim Group Downgrades Nimble Storage (NMBL) to Hold Following Deal With Hewlett Packard Enterprise (HPE)
Mar 23, 2017 07:59AM Maxim Group Reiterates Buy Rating and $10 PT on Cytosorbents (CTSO) Following Dr. Carl June's Election to the Advisory Board
Mar 23, 2017 07:48AM Maxim Group Reiterates Buy Rating and $10 PT on Adamis Pharmaceuticals (ADMP); 'Adamis Could Shine as EpiPen Falters'
Mar 20, 2017 05:31PM Maxim Group Starts Dave & Buster's (PLAY) at Buy
Mar 20, 2017 11:54AM Maxim Maintains Buy Rating and $10 PT on Cytosorbents (CTSO) Following Positive CytoSorb Cases to Treat HLH & CRS Relavance in Cancer Immunotherapy
Mar 17, 2017 08:30AM Nephros Announces $1.2 Million Private Placement
Mar 17, 2017 07:54AM Omeros Corp. (OMER) PT Raised to $22 at Maxim Group Following Strong 4Q Result; 'Omidria Gains Traction'
Mar 17, 2017 07:51AM Maxim Group Reiterates Buy Rating and $5 PT on Oncosec Medical (ONCS); 'Phase 2b of IL-12 Coming in 1h17'
Mar 16, 2017 11:16AM Maxim Group Reiterates Buy Rating and $110 PT on Cytosorbents (CTSO) Following Dr. Reddy Partnership
Mar 16, 2017 09:38AM Trovagene (TROV) Down 20% Following Q4 EPS Miss, Multiple Downgrades
Mar 16, 2017 07:42AM AEterna Zentaris (AEZS) PT Raised to $11 at Maxim Group; 'Zoptrex & Macrilen Could be Transformative'
Mar 16, 2017 07:31AM Maxim Group Downgrades TrovaGene (TROV) to Hold
Mar 16, 2017 07:28AM Maxim Group Upgrades Inovio Pharmaceuticals (INO) to Buy
Mar 15, 2017 08:08AM Maxim Group Reiterates Buy Rating and $14 PT on Mesoblast (MESO) Following Positive Data on Phase 2 Mesenchymal Precursor Cells Trial
Mar 14, 2017 09:37AM Cerecor Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2016
Mar 13, 2017 11:02AM Maxim Group Reiterates Buy Rating and $32 PT on Zynerba Pharma (ZYNE) Following Complete Enrollment for Phase2 ZYN002
Mar 13, 2017 07:55AM Bavarian Nordic (BAVA) PT Raised to $53 at Maxim Group on Combination Study of CV-201 & Tecentriq with Roche
Mar 10, 2017 07:24AM BioLife Solutions (BLFS) PT Raised to $4 at Maxim Group Following 4Q Results; 'Media Revenue Grows'
Mar 9, 2017 04:05PM ImmunoCellular Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Mar 9, 2017 08:02AM Maxim Group Downgrades Virtusa (VRTU) to Hold
View More Recent Stories View Older Stories